Format

Send to

Choose Destination
Hum Genomics. 2018 Feb 27;12(1):10. doi: 10.1186/s40246-018-0142-x.

Yale School of Public Health Symposium on tissue imaging mass spectrometry: illuminating phenotypic heterogeneity and drug disposition at the molecular level.

Author information

1
Department of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, USA.
2
Biomolecular Mass Spectrometry Imaging, National Resource for Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
3
Departments of Biochemistry and the Mass Spectrometry Research Center, Vanderbilt University School of Medicine, Nashville, USA.
4
Department of Bio-Imaging, Platform Science and Technology, GSK, King of Prussia, USA.
5
Biodesix Inc., Boulder, USA.
6
Pathology, Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Cambridge, UK.
7
Departments of Biochemistry and Ophthalmology and Visual Sciences, Vanderbilt University School of Medicine, Nashville, USA.
8
Department of Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, USA.
9
Computational and Systems Medicine, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.
10
Yale Cancer Center, Yale School of Medicine, Yale University, New Haven, USA.
11
Department of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, USA. vasilis.vasiliou@yale.edu.
12
Yale Cancer Center, Yale School of Medicine, Yale University, New Haven, USA. vasilis.vasiliou@yale.edu.
13
Department of Ophthalmology and Visual Science, Yale School of Medicine, Yale University, New Haven, USA. vasilis.vasiliou@yale.edu.

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center